Biopsy involves removal of cells or tissues from tumors located in various parts of the body and the devices used for this process are called biopsy devices. Biopsies are usually performed to identify and diagnose if the tumor is cancerous before designing a suitable treatment plan for the patient. These procedures are performed in two ways: needle-based minimally invasive procedures and open surgical procedures. Needle-based biopsy guns are handheld devices, which include a motor assembly attached to a biopsy needle, used to collect tissue samples from a patient’s body to detect malignancies. These devices may be automatic, semiautomatic, or manual, with a spring-loaded mechanism for a minimally invasive insertion through the skin to obtain samples for further laboratory testing. Physicians prefer conducting a minimally invasive needle-based procedure first, to obtain a sample of the timer to determine if it is malignant and needs to be surgically removed. The procedure is performed using image-guidance modalities such as X-ray imaging, magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound imaging. Biopsy devices use of three main types of needle-based technologies such as vacuum-assisted, core needle, and fine needle aspiration to draw samples.
The global needle based biopsy guns market is subject to rapid innovation and technological advancements, leading to constant product development ensuring better patient comfort and lesser trauma during and after surgery. Competitive pricing of products and reimbursement for biopsy procedures lead to higher adoption of biopsy devices, thereby driving the market. Expansion of the global needle based biopsy guns market is directly proportional to the incidence of cancer cases globally. According to the World Health Organization, in 2030, deaths caused due to cancer are expected to reach 13 billion worldwide. A rapid growth in incidence of cancer across the globe are anticipated to increase the number of patients undergoing biopsies. This, in turn, increases the adoption of needle based biopsy guns thereby, driving the market. Moreover, rapidly aging population are expected to further propel the global needle based biopsy guns market. Researchers consider cancer to be an age-related disease. Research reports suggest that patients over the age of 50 are more susceptible to cancer of the cervical, breast, and prostate. This is anticipated to propel the market during the forecast period.
The global needle based biopsy guns market can be segmented based on application, product type, and geography. In terms of application, the global needle based biopsy guns market is divided into vacuum-assisted biopsy devices (VAB), core needle biopsy devices (CNB), and fine needle aspiration biopsy devices (FNAB). Vacuum-assisted biopsy devices allows removal of larger tissue samples from the skin or breast without the need of an open surgical procedure. Based on product type, the needle based biopsy guns can be classified into disposable and reusable guns.
The global needle based biopsy guns market can been categorized into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global needle based biopsy guns market, followed by Europe. Expansion of the market in these region can be attributed to growing incidence of cancer, particularly in developed nations. The U.S. has a large number of cancer patients globally. Asia Pacific market constitutes Japan, China, India, Singapore, Malaysia, Thailand, and other Asian countries The global needle based biopsy guns market in Asia Pacific is projected to expand at a considerable pace due to rise in awareness about biopsy procedures and increase in ageing population.
Key players in the global needle based biopsy guns market include, Cardinal Health Inc., CareFusion Corporation, and Devicor Medical Products, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.